Table 5.
SF-12 questionnaire
| Baseline | 1 mo | Mean difference | 3 mo | Mean difference | 6 mo | Mean difference | |
| n = 30 | n = 20 | n = 18 | n = 13 | ||||
| PCS (SD) | 31.6 (10.5) | 35.8 (10.7) | +1.6 (8.8) | 32.7 (13.9) | +0.6 (14.4) | 31.1 (14.4) | 0.7 (11.2) |
| MCS (SD) | 34.6 (7.8) | 36.6 (7.8) | +3.5 (12.3) | 34.9 (7.0) | +0.3 (9.0) | 34.4 (7.7) | −0.9 (7.6) |
| Chronic pancreatitis | |||||||
| n = 11 | n = 9 | n = 8 | n = 8 | ||||
| PCS (SD) | 29.4 (9.1) | 36.7 (12.3) | +7.7 (12.9) | 34.7 (15.3) | 4.2 (13.9) | 34.7 (15.3) | 4.2 (13.9) |
| MCS (SD) | 35.8 (7.0) | 37.0 (9.0) | +0.9 (10.1) | 34.8 (7.2) | −2.8 (4.9) | 34.8 (7.2) | −2.8 (4.9) |
| Pancreatic ductal adenocarcinoma | |||||||
| n = 11 | n = 9 | n = 8 | n = 8 | ||||
| PCS (SD) | 32.9 (11.3) | 35.0 (9.7) | +0.0 (11.2) | 31.2 (13.4) | −2.2 (14.8) | 33.4 (16.5) | −0.9 (9.4) |
| MCS (SD) | 33.2 (8.2) | 36.2 (7.1) | +2.1 (9.9) | 35.1 (7.3) | 2.8 (10.9) | 35.1 (9.2) | 3.3 (8.3) |
Higher scores indicate improved condition.
Bold numbers indicate clinical relevance (Δ ≥ 3.0).
CP, chronic pancreatitis; MCS, mental score; PCS, physical score; PDAC, pancreatic ductal adenocarcinoma; SF-12, Short-Form survey.